Last reviewed · How we verify
Ornithine aspartate granule simulant — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Ornithine aspartate granule simulant (Ornithine aspartate granule simulant) — Xinhua Hospital, Shanghai Jiao Tong University School of Medicine.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ornithine aspartate granule simulant TARGET | Ornithine aspartate granule simulant | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ornithine aspartate granule simulant CI watch — RSS
- Ornithine aspartate granule simulant CI watch — Atom
- Ornithine aspartate granule simulant CI watch — JSON
- Ornithine aspartate granule simulant alone — RSS
Cite this brief
Drug Landscape (2026). Ornithine aspartate granule simulant — Competitive Intelligence Brief. https://druglandscape.com/ci/ornithine-aspartate-granule-simulant. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab